1. Home
  2. PFE vs SNY Comparison

PFE vs SNY Comparison

Compare PFE & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pfizer Inc.

PFE

Pfizer Inc.

HOLD

Current Price

$25.99

Market Cap

147.6B

Sector

Health Care

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$45.02

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFE
SNY
Founded
1849
1994
Country
United States
France
Employees
N/A
74846
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.6B
104.5B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
PFE
SNY
Price
$25.99
$45.02
Analyst Decision
Buy
Buy
Analyst Count
14
5
Target Price
$29.29
$58.00
AVG Volume (30 Days)
24.7M
2.4M
Earning Date
05-05-2026
04-23-2026
Dividend Yield
6.55%
3.47%
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$62,579,000,000.00
N/A
Revenue This Year
N/A
$3.49
Revenue Next Year
N/A
$6.10
P/E Ratio
$54.68
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$23.11
$42.28
52 Week High
$28.75
$52.68

Technical Indicators

Market Signals
Indicator
PFE
SNY
Relative Strength Index (RSI) 49.32 55.05
Support Level $25.02 $43.32
Resistance Level $25.99 $45.12
Average True Range (ATR) 0.40 0.55
MACD 0.04 0.16
Stochastic Oscillator 59.11 89.70

Price Performance

Historical Comparison
PFE
SNY

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: